• Chancroid
  • Obesity Panel
  • Anti Mullerian Hormone (AMH)
  • 18-Hydroxycorticosterone
  • Malignant neoplasm, intrahepatic bile duct
  • IgG Index, CSF
  • Myasthenia gravis
  • Human Immunodeficiency Virus 2 (HIV-2) DNA/RNA Qualitative or Quantitative
  • TGFB2 Gene Mutation Analysis
  • Phenosense Entry HIV Drug Resistance Assay
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

Methodology
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.